For: | Papaetis GS. Incretin-based therapies in prediabetes: Current evidence and future perspectives. World J Diabetes 2014; 5(6): 817-834 [PMID: 25512784 DOI: 10.4239/wjd.v5.i6.817] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v5/i6/817.htm |
Number | Citing Articles |
1 |
Georgios S. Papaetis. Liraglutide Therapy in a Prediabetic State: Rethinking the Evidence. Current Diabetes Reviews 2020; 16(7): 699 doi: 10.2174/1573399816666191230113446
|
2 |
Angelika Baranowska-Jurkun, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz. Chronic Microvascular Complications in Prediabetic States—An Overview. Journal of Clinical Medicine 2020; 9(10): 3289 doi: 10.3390/jcm9103289
|
3 |
Mohammed Altigani Abdalla, Harshal Deshmukh, Stephen Atkin, Thozhukat Sathyapalan. The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/2042018821989238
|
4 |
|
5 |
Lúbia Guaima Nascimento, Renata Cristina Rezende Macedo do Nascimento, Josélia Cintya Quintão Pena Frade, Eliete Bachrany Pinheiro, Wesley Magno Ferreira, Janice Sepúlveda Reis, Karla Fabiana Santana de Melo, Roberto Pontarolo, Mônica Soares Amaral Lenzi, José Vanilton de Almeida, Walter Jorge João, Hermelinda Cordeiro Pedrosa, Cassyano Januáro Correr, Wendel Coura-Vital. A new Brazilian regional scenario of Type 2 diabetes risk in the next ten years. Primary Care Diabetes 2021; 15(6): 1019 doi: 10.1016/j.pcd.2021.07.011
|
6 |
Ilka Günther, Gerald Rimbach, Sandra Nevermann, Cathrina Neuhauser, Verena Stadlbauer, Bettina Schwarzinger, Clemens Schwarzinger, Ignacio R. Ipharraguerre, Julian Weghuber, Kai Lüersen. Avens Root (Geum Urbanum L.) Extract Discovered by Target-Based Screening Exhibits Antidiabetic Activity in the Hen’s Egg Test Model and Drosophila melanogaster. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.794404
|
7 |
Chuan Xing, Jiaqi Zhang, Han Zhao, Bing He. Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment. International Journal of Women's Health 2022; : 91 doi: 10.2147/IJWH.S344542
|
8 |
Ahmed A.M Abdel-Hamid, Alaa El-Din L. Firgany. Modulatory effect of empagliflozin on cellular parameters of endocrine pancreas in experimental pre-diabetes. Annals of Anatomy - Anatomischer Anzeiger 2019; 224: 153 doi: 10.1016/j.aanat.2019.05.002
|
9 |
Pedro Henrique de A. Miranda, Kissyla Christine Duarte Lacerda, Carolina Morais Araújo, José Mario Barichello, Wanderson Geraldo Lima, Daniela Caldeira Costa. Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33727-x
|
10 |
Theo Audi Yanto, Akhil Deepak Vatvani, Timotius Ivan Hariyanto, Ketut Suastika. Glucagon-like peptide-1 receptor agonist and new-onset diabetes in overweight/obese individuals with prediabetes: A systematic review and meta-analysis of randomized trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(6): 103069 doi: 10.1016/j.dsx.2024.103069
|
11 |
Irene Roncero-Ramos, Rosa Jimenez-Lucena, Juan F. Alcala-Diaz, Cristina Vals-Delgado, Antonio P. Arenas-Larriva, Oriol A. Rangel-Zuñiga, Ana Leon-Acuña, María M. Malagon, Javier Delgado-Lista, Pablo Perez-Martinez, Jose M. Ordovas, Antonio Camargo, Jose Lopez-Miranda. Alpha cell function interacts with diet to modulate prediabetes and Type 2 diabetes. The Journal of Nutritional Biochemistry 2018; 62: 247 doi: 10.1016/j.jnutbio.2018.08.012
|
12 |
Alessia Pascale, Nicoletta Marchesi, Cristina Marelli, Adriana Coppola, Livio Luzi, Stefano Govoni, Andrea Giustina, Carmine Gazzaruso. Microbiota and metabolic diseases. Endocrine 2018; 61(3): 357 doi: 10.1007/s12020-018-1605-5
|
13 |
Habib Yaribeygi, Farin Rashid Farrokhi, Mohammed Altigani Abdalla, Thozhukat Sathyapalan, Maciej Banach, Tannaz Jamialahmadi, Amirhossein Sahebkar, Gaetano Santulli. The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes. Journal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/6518221
|
14 |
Georgios S. Papaetis. Pioglitazone, Bladder Cancer, and the Presumption of Innocence. Current Drug Safety 2022; 17(4): 294 doi: 10.2174/1574886317666220304124756
|
15 |
Sam Dagogo-Jack. Diabetes Mellitus in Developing Countries and Underserved Communities. 2017; : 7 doi: 10.1007/978-3-319-41559-8_2
|
16 |
Ben Brannick, Anne Wynn, Samuel Dagogo-Jack. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Experimental Biology and Medicine 2016; 241(12): 1323 doi: 10.1177/1535370216654227
|
17 |
Alexandra Aliluev, Sophie Tritschler, Michael Sterr, Lena Oppenländer, Julia Hinterdobler, Tobias Greisle, Martin Irmler, Johannes Beckers, Na Sun, Axel Walch, Kerstin Stemmer, Alida Kindt, Jan Krumsiek, Matthias H. Tschöp, Malte D. Luecken, Fabian J. Theis, Heiko Lickert, Anika Böttcher. Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice. Nature Metabolism 2021; 3(9): 1202 doi: 10.1038/s42255-021-00458-9
|
18 |
Mahmoud Al Rifai, Michael D. Shapiro. A multifaceted approach for management of prediabetes and its associated cardiovascular risk. Diabetes/Metabolism Research and Reviews 2020; 36(6) doi: 10.1002/dmrr.3314
|
19 |
Wentao Zhu, Pei Shi, Jiwei Fu, An Liang, Ting Zheng, Xiaoping Wu, Songsong Yuan. Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01752-5
|
20 |
Caitlin Victoria Hall, John Luke Twelves, Manish Saxena, Leonardo Scapozza, Thomas Gurry. Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial. British Journal of Nutrition 2024; 132(1): 68 doi: 10.1017/S0007114524000904
|
21 |
Georgios S. Papaetis, Panagiota K. Filippou, Kiriaki G. Constantinidou, Christina S. Stylianou. Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome. Clinical Drug Investigation 2020; 40(8): 695 doi: 10.1007/s40261-020-00942-2
|
22 |
Vala Hamidi, Kayla Riggs, Liang Zhu, Karla Bermudez Saint Andre, Christian Westby, Sara Coverdale, Amy Dursteler, Hongyu Wang, Charles Miller III, Heinrich Taegtmeyer, Absalon D. Gutierrez. Acute Exenatide Therapy Attenuates Postprandial Vasodilation in Humans with Prediabetes: A Randomized Controlled Trial. Metabolic Syndrome and Related Disorders 2020; 18(5): 225 doi: 10.1089/met.2019.0102
|
23 |
Thomas Wilke, Sabrina Mueller, Antje Groth, Bjoern Berg, Andreas Fuchs, Mirko Sikirica, John Logie, Alan Martin, Ulf Maywald. Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis. Diabetes Therapy 2016; 7(1): 105 doi: 10.1007/s13300-015-0149-4
|
24 |
Radia Khan, Zoey Chua, Jia Tan, Yingying Yang, Zehuan Liao, Yan Zhao. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina 2019; 55(9): 546 doi: 10.3390/medicina55090546
|